Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Lightchain Capitallightchain-capital.com · Low evidenceLightchain Capital is a venture capital fund that invests in early-stage life sciences companies focused on improving cancer patient outcomes. The fund supports innovative therapies, such as C4 Therapeutics' CFT1946, a targeted treatment for BRAF V600 mutant solid tumors.
Parse Score